ArticleFrontiers in immunology2025

Lipid and immune dysregulation and risk of metabolic disorders after HCV clearance in HIV/HCV-coinfected participants with cACLD: a retrospective study.

Ana Virseda-Berdices et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.